Fidelity Disruptive Medicine ETF Rating → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free FMED Stock Alerts $24.23 -0.25 (-1.02%) (As of 05/10/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsSocial MediaStock AnalysisChartHoldingsOwnershipRatingsSocial Media Fidelity Disruptive Medicine ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FMED Aggregate RatingModerate Buy2.74Holdings in FMED have an aggregate rating of Moderate Buy based on 606 analyst ratings issued in the past year covering 46 companies (90.8% of the portfolio).FMED Aggregate Price Target$30.2224.74% UpsideHigh Prediction$38.37Average Prediction$30.22Low Prediction$22.83Holdings in FMED have an aggregate price target of $30.22 and a range of $22.83 to $38.37 covering 46 companies (90.8% of the portfolio).FMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy34 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Fidelity Disruptive Medicine ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 46 FMED Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.90%BSXBoston Scientific$73.69-0.6%4 of 5 stars2.95$75.09 1.9%21Insider SellingOptions Volume4.07%UNHUnitedHealth Group$512.94+1.2%5 of 5 stars2.83$570.05 11.1%183.71%DHRDanaher$253.38+0.8%5 of 5 stars2.64$267.31 5.5%14Dividend AnnouncementShort Interest ↓3.59%CNCCentene$77.79+0.2%5 of 5 stars2.50$85.23 9.6%123.35%ISRGIntuitive Surgical$386.70+0.3%5 of 5 stars2.76$396.17 2.4%17Short Interest ↑3.10%ALNYAlnylam Pharmaceuticals$150.47-0.6%4 of 5 stars2.59$216.19 43.7%17Analyst ForecastShort Interest ↑Analyst Revision2.98%PODDInsulet$165.90-6.6%5 of 5 stars2.82$240.25 44.8%17Earnings ReportAnalyst UpgradeAnalyst RevisionNews CoverageGap UpHigh Trading Volume2.67%EXASExact Sciences$53.51-1.2%5 of 5 stars2.92$95.40 78.3%13Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageHigh Trading Volume2.66%INSPInspire Medical Systems$167.83-3.8%5 of 5 stars2.69$256.53 52.9%16Earnings ReportAnalyst DowngradeAnalyst RevisionNews Coverage2.54%LEGNLegend Biotech$43.24-5.0%2 of 5 stars2.92$82.64 91.1%12Upcoming EarningsAnalyst ForecastShort Interest ↑2.54%SYKStryker$330.65-0.1%5 of 5 stars2.78$365.94 10.7%18Dividend Announcement2.48%PENPenumbra$212.15+1.3%5 of 5 stars2.70$300.64 41.7%10Earnings ReportAnalyst Forecast2.38%MRKMerck & Co., Inc.$130.03-0.2%5 of 5 stars2.58$131.33 1.0%122.38%REGNRegeneron Pharmaceuticals$973.80+0.6%4 of 5 stars2.70$981.71 0.8%20Positive News2.23%EWEdwards Lifesciences$86.72-0.8%5 of 5 stars2.56$93.27 7.5%18Analyst ForecastShort Interest ↑2.21%ARGXargenx$374.63-2.1%3 of 5 stars2.71$528.16 41.0%21Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage2.20%LFSTLifeStance Health Group$6.86-3.7%1 of 5 stars2.17$8.83 28.8%6Earnings ReportNews Coverage2.20%LLYEli Lilly and Company$760.26-1.5%5 of 5 stars2.84$757.95 -0.3%19Earnings ReportDividend AnnouncementShort Interest ↓2.14%TMOThermo Fisher Scientific$593.35+2.7%5 of 5 stars2.71$607.35 2.4%172.05%RPRXRoyalty Pharma$28.09+0.4%5 of 5 stars3.00$46.75 66.4%4Earnings ReportAnalyst DowngradeNews Coverage2.03%VEEVVeeva Systems$203.79-0.1%5 of 5 stars2.65$234.90 15.3%20Short Interest ↓1.91%DXCMDexCom$127.05-0.9%5 of 5 stars2.93$141.67 11.5%14Analyst DowngradeShort Interest ↓Positive News1.88%RGENRepligen$166.81+1.2%4 of 5 stars2.89$197.75 18.5%91.84%MASIMasimo$121.76-1.9%5 of 5 stars2.43$138.71 13.9%7Earnings ReportAnalyst ForecastNews Coverage1.70%GKOSGlaukos$110.45+2.6%4 of 5 stars2.82$108.64 -1.6%11Short Interest ↑1.57%TECHBio-Techne$80.91+1.6%4 of 5 stars2.82$80.50 -0.5%11Positive News1.50%CYTKCytokinetics$62.10-3.0%4 of 5 stars2.87$81.60 31.4%15Earnings ReportAnalyst ForecastInsider SellingAnalyst RevisionNews Coverage1.37%JANXJanux Therapeutics$48.92-5.8%3 of 5 stars3.00$64.83 32.5%7Analyst ForecastAnalyst RevisionNews Coverage1.35%BRKRBruker$75.71-0.7%5 of 5 stars2.43$84.86 12.1%71.27%HUMHumana$335.58+0.3%5 of 5 stars2.47$424.50 26.5%19Analyst Revision1.27%EVHEvolent Health$24.46-9.3%3 of 5 stars2.92$42.00 71.7%12Analyst ForecastNews CoverageGap DownHigh Trading Volume1.25%PRVAPrivia Health Group$17.97-0.3%4 of 5 stars2.83$26.58 47.9%12Analyst ForecastAnalyst RevisionNews Coverage1.25%TXG10x Genomics$25.99-1.5%5 of 5 stars2.58$48.50 86.6%12Gap Down1.24%XENEXenon Pharmaceuticals$40.54-4.6%3 of 5 stars3.00$59.11 45.8%9Earnings ReportAnalyst ForecastNews CoverageGap Down1.24%RMDResMed$213.82-1.4%5 of 5 stars2.70$202.80 -5.2%10Insider SellingShort Interest ↑1.23%WSTWest Pharmaceutical Services$364.19-0.4%5 of 5 stars2.80$435.20 19.5%5Insider Selling1.13%SRPTSarepta Therapeutics$131.82-0.4%4 of 5 stars2.79$160.60 21.8%141.12%ALGNAlign Technology$271.70-3.1%5 of 5 stars2.50$353.00 29.9%10Short Interest ↓Positive News1.11%PHRPhreesia$21.37-2.7%5 of 5 stars2.86$31.62 47.9%14Positive News1.10%PCVXVaxcyte$65.19-0.6%1 of 5 stars3.00$78.50 20.4%4Earnings ReportAnalyst ForecastNews Coverage1.09%ASNDAscendis Pharma A/S$133.46+0.2%1 of 5 stars2.88$173.88 30.3%80.90%VRTXVertex Pharmaceuticals$422.78+0.9%4 of 5 stars2.48$432.18 2.2%25Earnings ReportAnalyst Forecast0.86%AGLagilon health$5.19-1.3%2 of 5 stars2.18$9.32 79.6%17Analyst Revision0.77%NTRANatera$105.29+10.2%1 of 5 stars3.00$87.86 -16.6%15Earnings ReportAnalyst DowngradeInsider SellingNews CoverageGap UpHigh Trading Volume0.76%TNDMTandem Diabetes Care$44.36+0.7%4 of 5 stars2.80$43.80 -1.3%10Positive News0.64%IRTCiRhythm Technologies$99.01-0.9%1 of 5 stars3.00$134.00 35.3%7 This page (NASDAQ:FMED) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & CompanyRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
